子宫内膜癌的手术入路与复发模式:SUPeR研究,一项多中心回顾性观察性研究
该多中心回顾性观察性研究纳入2017年1月至2022年6月五家意大利妇科肿瘤中心接受微创手术治疗的1028例表观早期子宫内膜癌患者,中位随访36个月共77例复发,复发率与LAP2及LACE试验的剖腹手术历史队列相比无显著差异,未发现微创手术特有的复发模式。
要点
- 微创手术组复发率7.4%与历史剖腹手术队列7.9%相比无显著差异(OR 0.9395,95%CI 0.6901-1.2792)。
- 局部、腹部、淋巴结及多部位复发模式无显著差异,历史队列远处部位复发可能性更高。
- 术后低/中危患者较中高/高危患者局部复发可能性更高,平均首次复发时间为19个月。
核心结论
- 微创手术似乎可安全用于早期子宫内膜癌的治疗,未发现与微创手术特异性相关的复发模式。
研究设计与样本
- 多中心回顾性观察性研究,设置于五家意大利妇科肿瘤转诊中心。
- 纳入2017年1月至2022年6月接受微创手术且经证实复发的表观早期子宫内膜癌患者,共1028例接受微创手术患者中发生77例复发。
- 剖腹手术历史队列取自LAP2试验与LACE试验。
- 中位随访时间36个月。
主要发现
- 微创手术队列复发率与历史队列相比无显著差异(7.4% vs 7.9%,OR 0.9395,95%CI 0.6901-1.2792)。
- 局部、腹部、淋巴结及多部位复发模式未见显著差异;历史队列患者远处部位复发可能性更高。
- 术后低/中危患者较中高/高危患者局部复发可能性更高。
- 平均首次复发时间为19个月,各复发模式之间首次复发时间无显著差异。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
STUDY OBJECTIVE: To evaluate recurrence rate and pattern in apparently early-stage endometrial cancer (EC) treated with minimally invasive surgery (MIS) and compare it to the "historical" populations treated by laparotomy. Secondary outcomes were to establish if, among MIS recurrent patients, intermediate-high/high-risk patients presented the same recurrence pattern compared to those at low/intermediate-risk and to evaluate time to first recurrence (TTR) of the study population. DESIGN: Multicenter retrospective observational study. SETTING: Five Italian Gynecologic Oncology referral centers. PATIENTS: All patients with proven recurrence of apparently early-stage EC treated with MIS from January 2017 to June 2022 . The laparotomic historical cohort was obtained from Laparoscopy Compared With Laparotomy for Comprehensive Surgical Staging of Uterine Cancer: Gynecologic Oncology Group Study (LAP2) and Laparoscopic Approach to Cancer of the Endometrium trials. INTERVENTIONS: Evaluation of recurrence rate and pattern. MEASUREMENTS AND MAIN RESULTS: Seventy-seven recurrences occurred on the total of 1028 patients treated with MIS for apparently early-stage EC during a median follow-up time of 36 months. The rate of recurrence in our cohort did not differ significantly from the rate of the historical cohort (7.4% vs 7.9%, odds ratio 0.9395, 95% CI 0.6901-1.2792). No significant differences were noticed for local, abdominal, nodal, and multiple site recurrence patterns; distant site recurrence appeared more likely in patients from the historical cohort. Postoperative low/intermediate risk patients had a higher likelihood of local recurrence compared to intermediate-high/high risk patients. Mean TTR was 19 months. No significant difference of TTR was observed for each pattern of recurrence compared to others. CONCLUSION: MIS appears to be safe for the treatment of early-stage EC. We did not identify any recurrence pattern specifically associated with MIS in early-stage EC.
引用
- Puppo A, Migliaretti G, Landoni F, et al. SUrgical Access and Pattern of Recurrence of Endometrial Cancer: The SUPeR Study, a Multicenter Retrospective Observational Study. J Minim Invasive Gynecol. 2024. PMID: 38301845. doi:10.1016/j.jmig.2024.01.016
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。